๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Neurohormonal activation in severe heart failure: Relations to patient death and the effect of treatment with flosequinan

โœ Scribed by Gordon W. Moe; Jean L. Rouleau; Lynne Charbonneau; Guy Proulx; J.Malcolm O. Arnold; Christian Hall; Jacques de Champlain; Aiala Barr; Pierre Sirois; Milton Packer; Candian PROFILE investigators

Book ID
117008553
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
889 KB
Volume
139
Category
Article
ISSN
1097-6744

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A comparison of the effects of captopril
A comparison of the effects of captopril and flosequinan in patients with severe heart failure
โœ A. J. Cowley; R. D. Wynne; A. Swami; J. Birkhead; A. Skene; J. R. Hampton ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer US ๐ŸŒ English โš– 542 KB

Angiotensin converting enzyme inhibitors have greatly improved the treatment of patients with chronic heart failure but they are not effective in all patients, and their use may be limited by side effects. There is, therefore, a need to investigate new drugs and to compare their efficacy with angiot

The central haemodynamic effects of a si
The central haemodynamic effects of a single intravenous dose of flosequinan in patients with severe heart failure
โœ H. Markus; A. J. Cowley ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 332 KB

The acute central haemodynamic and neuroendocrine effects of intravenous flosequinan were studied in a group of 10 patients with severe heart failure. Flosequinan improved cardiac output by a maximum of 1.59 l.min-1, it reduced pulmonary capillary wedge pressure by 11.9 mm Hg and it also caused a re